152 related articles for article (PubMed ID: 4061066)
1. The effect on the human uterus of two newly developed competitive inhibitors of oxytocin and vasopressin.
Akerlund M; Carlsson AM; Melin P; Trojnar J
Acta Obstet Gynecol Scand; 1985; 64(6):499-504. PubMed ID: 4061066
[TBL] [Abstract][Full Text] [Related]
2. Vasotocin analogues which competitively inhibit vasopressin stimulated uterine activity in healthy women.
Akerlund M; Hauksson A; Lundin S; Melin P; Trojnar J
Br J Obstet Gynaecol; 1986 Jan; 93(1):22-7. PubMed ID: 3942702
[TBL] [Abstract][Full Text] [Related]
3. Synthetic antagonists of the myometrial response to vasopressin and oxytocin.
Melin P; Trojnar J; Johansson B; Vilhardt H; Akerlund M
J Endocrinol; 1986 Oct; 111(1):125-31. PubMed ID: 3783079
[TBL] [Abstract][Full Text] [Related]
4. Receptors for and myometrial responses to oxytocin and vasopressin in preterm and term human pregnancy: effects of the oxytocin antagonist atosiban.
Bossmar T; Akerlund M; Fantoni G; Szamatowicz J; Melin P; Maggi M
Am J Obstet Gynecol; 1994 Dec; 171(6):1634-42. PubMed ID: 7802081
[TBL] [Abstract][Full Text] [Related]
5. Vasopressin effects on isolated non-pregnant myometrium and uterine arteries and their inhibition by deamino-ethyl-lysine-vasopressin and deamino-ethyl-oxytocin.
Akerlund M; Kostrzewska A; Laudănski T; Melin P; Vilhardt H
Br J Obstet Gynaecol; 1983 Aug; 90(8):732-8. PubMed ID: 6882706
[TBL] [Abstract][Full Text] [Related]
6. Effect of the oxytocin antagonist atosiban (1-deamino-2-D-tyr(OET)-4-thr-8-orn-vasotocin/oxytocin) on nocturanl myometrial contractions, maternal cardiovascular function, transplacental passage, and fetal oxygenation in the pregnant baboon during the last third of gestation.
Nathanielsz PW; Honnebier MB; Mecenas C; Jenkins SL; Holland ML; Demarest K
Biol Reprod; 1997 Aug; 57(2):320-4. PubMed ID: 9241045
[TBL] [Abstract][Full Text] [Related]
7. Uterine blood flow and myometrial activity at menstruation, and the action of vasopressin and a synthetic antagonist.
Hauksson A; Akerlund M; Melin P
Br J Obstet Gynaecol; 1988 Sep; 95(9):898-904. PubMed ID: 3191063
[TBL] [Abstract][Full Text] [Related]
8. FE 200 440: a selective oxytocin antagonist on the term-pregnant human uterus.
Nilsson L; Reinheimer T; Steinwall M; Akerlund M
BJOG; 2003 Nov; 110(11):1025-8. PubMed ID: 14592588
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of barusiban and atosiban on oxytocin-induced contractions of myometrium from preterm and term pregnant women.
Pierzynski P; Lemancewicz A; Reinheimer T; Akerlund M; Laudanski T
J Soc Gynecol Investig; 2004 Sep; 11(6):384-7. PubMed ID: 15350251
[TBL] [Abstract][Full Text] [Related]
10. Potential use of oxytocin and vasopressin V1a antagonists in the treatment of preterm labour and primary dysmenorrhoea.
Akerlund M; Melin P; Maggi M
Adv Exp Med Biol; 1995; 395():595-600. PubMed ID: 8714023
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of 1-deamino-[D-Tyr(Oethyl)2, Thr4, Orn8] vasotocin, an oxytocin antagonist, in animal models of uterine contractility and preterm labor: a new tocolytic agent.
Hahn DW; Demarest KT; Ericson E; Homm RE; Capetola RJ; McGuire JL
Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 1):977-82. PubMed ID: 3674173
[TBL] [Abstract][Full Text] [Related]
12. Oxytocin receptor blockade: a new principle in the treatment of preterm labor?
Andersen LF; Lyndrup J; Akerlund M; Melin P
Am J Perinatol; 1989 Apr; 6(2):196-9. PubMed ID: 2540760
[TBL] [Abstract][Full Text] [Related]
13. Effects of a vasopressin antagonist in women with dysmenorrhea.
Valentin L; Sladkevicius P; Kindahl H; Broeders A; Marsal K; Melin P
Gynecol Obstet Invest; 2000; 50(3):170-7. PubMed ID: 11014949
[TBL] [Abstract][Full Text] [Related]
14. Antagonists for the human oxytocin receptor: an in vitro study.
Maggi M; Fantoni G; Baldi E; Cioni A; Rossi S; Vannelli GB; Melin P; Akerlund M; Serio M
J Reprod Fertil; 1994 Jul; 101(2):345-52. PubMed ID: 7932368
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of action of the oxytocin antagonist 1-deamino-2-D-Tyr-(OEt)-4-Thr-8-Orn-oxytocin.
López Bernal A; Phipps SL; Rosevear SK; Turnbull AC
Br J Obstet Gynaecol; 1989 Sep; 96(9):1108-10. PubMed ID: 2804016
[No Abstract] [Full Text] [Related]
16. Pharmacokinetics in the human of a new synthetic vasopressin and oxytocin uterine antagonist.
Lundin S; Akerlund M; Fagerström PO; Hauksson A; Melin P
Acta Endocrinol (Copenh); 1986 Aug; 112(4):465-72. PubMed ID: 3751461
[TBL] [Abstract][Full Text] [Related]
17. Oxytocin receptor subtypes in the pregnant rat myometrium and decidua: pharmacological differentiations.
Chan WY; Chen DL; Manning M
Endocrinology; 1993 Mar; 132(3):1381-6. PubMed ID: 8382600
[TBL] [Abstract][Full Text] [Related]
18. Profile of an oxytocin antagonist, RWJ 22164 for treatment of preterm labor in laboratory models of uterine contractility.
Demarest KT; Hahn DW; Ericson E; Capetola RJ; Fuchs AR; McGuire JL
Am J Perinatol; 1989 Apr; 6(2):200-4. PubMed ID: 2712917
[TBL] [Abstract][Full Text] [Related]
19. Receptor binding of oxytocin and vasopressin antagonists and inhibitory effects on isolated myometrium from preterm and term pregnant women.
Akerlund M; Bossmar T; Brouard R; Kostrzewska A; Laudanski T; Lemancewicz A; Serradeil-Le Gal C; Steinwall M
Br J Obstet Gynaecol; 1999 Oct; 106(10):1047-53. PubMed ID: 10519430
[TBL] [Abstract][Full Text] [Related]
20. Contractile effect of oxytocin and 1-deamino-1-carba-2-tyrosine (0-methyl)-oxytocin in myometrial tissue from non-pregnant and term pregnant women.
Norström A; Andersson A; Vilhardt H
Acta Endocrinol (Copenh); 1990 May; 122(5):566-8. PubMed ID: 2353554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]